Cardurion Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Cardurion Pharmaceuticals's estimated annual revenue is currently $15.7M per year.
- Cardurion Pharmaceuticals's estimated revenue per employee is $188,614
- Cardurion Pharmaceuticals's total funding is $622M.
Employee Data
- Cardurion Pharmaceuticals has 83 Employees.
- Cardurion Pharmaceuticals grew their employee count by 41% last year.
Cardurion Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO and President | Reveal Email/Phone |
2 | President and CEO | Reveal Email/Phone |
3 | Chief Medical and Scientific Officer | Reveal Email/Phone |
4 | Founder and Chief Strategy Officer | Reveal Email/Phone |
5 | Chief Business Officer | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | Founder and Chairman | Reveal Email/Phone |
8 | VP/Head, Biometrics | Reveal Email/Phone |
9 | SVP, Technical Operations | Reveal Email/Phone |
10 | VP, Information Technology | Reveal Email/Phone |
Cardurion Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Cardurion Pharmaceuticals?
Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. Cardurion's product pipeline includes our lead clinical asset, CRD-733, a PDE-9 inhibitor with the potential to improve cardiac function in heart failure patients. Cardurion has an exclusive licensing agreement with Astellas for the development and commercialization of CRD-733. Additionally, Cardurion has a strong cardiovascular development partnership with Takeda which is fueling drug discovery and preclinical development work being conducted in our internal research laboratories.
keywords:N/A
$622M
Total Funding
83
Number of Employees
$15.7M
Revenue (est)
41%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cardurion Pharmaceuticals News
Cardurion Pharmaceuticals is a clinical-stage biotechnology company focused on the discovery and development of novel, next-generation...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12M | 83 | 1% | $18M |
#2 | $20.2M | 83 | -8% | N/A |
#3 | $20.8M | 83 | -2% | N/A |
#4 | $11.7M | 83 | -7% | $174M |
#5 | $26.8M | 83 | 20% | N/A |